Workflow
MacroGenics (MGNX) Reports Q2 Loss, Tops Revenue Estimates
MacroGenicsMacroGenics(US:MGNX) ZACKS·2025-08-15 06:15

MacroGenics (MGNX) came out with a quarterly loss of 0.57pershareversustheZacksConsensusEstimateofalossof0.57 per share versus the Zacks Consensus Estimate of a loss of 0.59. This compares to a loss of 0.89pershareayearago.Thesefiguresareadjustedfornonrecurringitems.Thisquarterlyreportrepresentsanearningssurpriseof+3.390.89 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +3.39%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of 0.61 per share when it actually produced a loss of $0.65, delivering a surprise of -6.56%.Over the last four quarters, the comp ...